Sell on Novo Nordisk A/S: slowing growth, downgraded 2025 guidance, rising GLP-1 competition, pricing/patent risks, limited ...

The medical watchdog group Do No Harm is urging the FDA to crack down on pharmacies that offer transgender hormones online.

Using nationally representative data, the authors found that for common physician-administered drugs, hospitals’ unilaterally set cash prices are frequently lower than their median—and sometimes even ...

Hims & Hers received a flurry of upgrades, though most analysts are opting to stay on the sidelines. Here’s why.

American talk show host Oprah Winfrey stole the spotlight at the recent Paris Fashion Week, not just for her chic style but ...

Eli Lilly (LLY) stock holds Morgan Stanley's $1,313 target as Mounjaro and Zepbound prescriptions rise week-over-week, maintaining 60% GLP-1 market share.

Susvimo is an FDA-approved eye implant for diabetic macular edema that may reduce monthly injections to just two treatments a year while maintaining vision outcomes.

A curated partner ecosystem uniting methodology, technology, and managed services to move life sciences from compliance ...

It's no secret that celebrity access to Ozempic negatively impacts diabetes patients, but they might be unrecognizable by the ...

The imbalance between pharma’s investment in brand advertising versus corporate and public affairs has become a strategic liability amid the most challenging regulatory conditions the drug industry ...

In a bid to attract customers to the pharmacy, ShopRite has put out the welcome mat to people filling prescriptions for GLP-1 ...

A telemedicine platform offering access to board-certified physicians for insomnia treatment through an asynchronous ...